The impact of posttraumatic stress disorder on cannabis quit success

American Journal of Drug and Alcohol Abuse

Volumn 41, Issue 4, 2015, Pages 339-344

  Bonn Miller, Marcel O ^a,b,c   Moos, Rudolf H ^a,e   Boden, Matthew Tyler ^a   Long, W Robert ^d   Kimerling, Rachel ^a   Trafton, Jodie A ^a,e  

^a VA PALO ALTO HEALTH CARE SYSTEM   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d UNIVERSITY OF LEEDS   (United Kingdom)

^e STANFORD UNIVERSITY   (United States)

Author keywords

Cannabis; Cessation; Marijuana; Posttraumatic stress disorder (PTSD)

Indexed keywords

ADULT; ALCOHOL ABSTINENCE; ANXIETY DISORDER; ARTICLE; CANNABIS USE; DISEASE ASSOCIATION; DRUG WITHDRAWAL; DSM-IV; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MOOD DISORDER; POSTTRAUMATIC STRESS DISORDER; PROSPECTIVE STUDY; RELAPSE; SMOKING CESSATION; TOBACCO USE; UNITED STATES; VETERAN; COMPLICATION; DRINKING BEHAVIOR; MARIJUANA ABUSE; MIDDLE AGED; PSYCHOLOGY; RECURRENT DISEASE; SMOKING; STATISTICS AND NUMERICAL DATA; STRESS DISORDERS, POST-TRAUMATIC;

ALCOHOL DRINKING; FEMALE; HUMANS; MALE; MARIJUANA ABUSE; MIDDLE AGED; RECURRENCE; SMOKING; STRESS DISORDERS, POST-TRAUMATIC; UNITED STATES; VETERANS;

EID: 84946050955     PISSN: 00952990     EISSN: 10979891     Source Type: Journal    
DOI: 10.3109/00952990.2015.1043209     Document Type: Article

References (50)

1. Bonn-Miller MO, Harris AH, Trafton JA. Prevalence of cannabis use disorder diagnoses among veterans in 2002, 2008, and 2009. Psycholog Services 2012;9:404-416.
2. Substance Abuse and Mental Health Services Administration (SAMHSA). Results from the 2012 National Survey on Drug Use and Health: summary of National Findings. Rockville (MD): SAMHSA; 2013.
3. Institute of Medicine. Treatment for posttraumatic stress disorder in military and veteran populations: final assessment. Washington, DC: Institute of Medicine; 2014.
4. Bremner JD, Southwick SM, Darnell A, Charney DS. Chronic PTSD in Vietnam combat veterans: course of illness and substance abuse. Am J Psychiatry 1996;153:369-375.
5. Kilpatrick DG, Acierno R, Saunders B, Resnick HS, Best CL, Schnurr PP. Risk factors for adolescent substance abuse and dependence: data from a national sample. J Consul Clin Psychol 2000;68:19-30.
6. Vlahov D, Galea S, Resnick H, Ahern J, Boscarino JA, Bucuvalas M, Gold J, et al. Increased use of cigarettes, alcohol, and marijuana among Manhattan, New York, residents after the September 11th terrorist attacks. Am J Epidemiol 2002;155:988-996.
7. Program Evaluation and Resource Center VA; 2014.
8. Bonn-Miller MO, Boden MT, Bucossi MM, Babson KA. Selfreported cannabis use characteristics, patterns and helpfulness among medical cannabis users. Am J Drug Alcohol Abuse 2014;40: 23-30.
9. Bohnert KM, Perron BE, Ashrafioun L, Kleinberg F, Jannausch M, Ilgen MA. Positive posttraumatic stress disorder screens among first-time medical cannabis patients: prevalence and association with other substance use. Addict Behav 2014;39:1414-1417.
10. Cougle JR, Bonn-Miller MO, Vujanovic AA, Zvolensky MJ, Hawkins KA. Posttraumatic stress disorder and cannabis use in a nationally representative sample. Psychol Addictive Behav 2011; 25:554-558.
11. Bonn-Miller MO, Vujanovic AA, Drescher KD. Cannabis use among military veterans after residential treatment for posttraumatic stress disorder. Psychol Addictive Behav 2011;25:485-491.
12. Bonn-Miller MO, Vujanovic AA, Feldner MT, Bernstein A, Zvolensky MJ. Posttraumatic stress symptom severity predicts marijuana use coping motives among traumatic event-exposed marijuana users. J Traumatic Stress 2007;20:577-586.
13. Boden MT, Babson KA, Vujanovic AA, Short NA, Bonn-Miller MO. Posttraumatic stress disorder and cannabis use characteristics among military veterans with cannabis dependence. Am J Addictions/Am Acad Psychiat Alcohol Addict 2013;22:277-284.
14. Bonn-Miller MO, Boden MT, Vujanovic AA, Drescher KD. A prospective investigation of the impact of cannabis use disorders on posttraumatic stress disorder symptoms among veterans in residential treatment. Psycholog Trauma: Theory Res Pract Policy 2013;5:193-200.
15. Ouimette PC, Ahrens C, Moos RH, Finney JW. Posttraumatic stress disorder in substance abuse patients: relationship to 1-year posttreatment outcomes. Psychol Addict Behav 1997;11:34-47.
16. Ouimette PC, Finney JW, Moos RH. Two-year posttreatment functioning and coping of substance abuse patients with posttraumatic stress disorder. Psychol Addict Behav 1999;13:105-114.
17. Read JP, Brown PJ, Kahler CW. Substance use and posttraumatic stress disorders: symptom interplay and effects on outcome. Addict Behav 2004;29:1665-1672.
18. Larimer ME, Palmer RS, Marlatt GA. Relapse prevention. An overview of Marlatt's cognitive-behavioral model. Alcohol Res Health 1999;23:151-160.
19. Ouimette P, Brown PJ. Trauma and substance abuse: causes, consequences, and treatment of comorbid disorders, 1st ed. Washington, DC: American Psychological Association; 2003.
20. Ouimette PC, Brown PJ, Najavits LM. Course and treatment of patients with both substance use and posttraumatic stress disorders. Addict Behav 1998;23:785-795.
21. Hall SM, Havassy BE, Wasserman DA. Commitment to abstinence and acute stress in relapse to alcohol, opiates, and nicotine. J Consult Clin Psychol 1990;58:175-181.
22. Moore BA, Budney AJ. Relapse in outpatient treatment for marijuana dependence. J Substance Abuse Treat 2003;25:85-89.
23. Cunningham JA. Remissions from drug dependence: is treatment a prerequisite? Drug Alcohol Depend 2000;59:211-213.
24. Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, Walters EE. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 2005;62:593-602.
25. Seal KH, Metzler TJ, Gima KS, Bertenthal D, Maguen S, Marmar CR. Trends and risk factors for mental health diagnoses among Iraq and Afghanistan veterans using Department of Veterans Affairs health care, 2002-2008. Am J Public Health 2009;99:1651-1658.
26. Weiss DS, Marmar CR, Schlenger WE, Fairbank JA, Jordan BK, Hough RL, Kulka RA. The prevalence of lifetime and partial posttraumatic stress disorder in Vietnam theater veterans. J Traumatic Stress 1992;5:365-376.
27. McRae AL, Budney AJ, Brady KT. Treatment of marijuana dependence: a review of the literature. J Substance Abuse Treat 2003;24:369-376.
28. Blake DD, Weathers FW, Nagy LM, Kaloupek DG, Gusman FD, Charney DS, Keane TM. The development of a Clinician-Administered PTSD Scale. J Traumatic Stress 1995;8:75-90.
29. American Psychiatric Association (APA). Diagnostic and statistical manual of mental disorders: DSM-IV-TR, 4th ed. Washington, DC: APA; 2000.
30. First MB, Spitzer RL, Gibbon M, Williams JBW. Structured clinical interview for DSM-IV-TR Axis I disorders, Research Version, Non-patient edition. New York: Biometrics Research, New York State Psychiatric Institute; 2002.
31. Weathers FW, Keane TM, Davidson JR. Clinician-administered PTSD scale: a review of the first ten years of research. Depression Anxiety 2001;13:132-156.
32. Weathers FW, Ruscio AM, Keane TM. Psychometric properties of nine scoring rules for the Clinician-Administered Posttraumatic Stress Disorder Scale. Psychological Assess 1999;11:124-133.
33. Sobell L, Sobell M. Timeline follow-back: a technique for assessing self-reported ethanol consumption. In: Allen J, Litten RZ, eds. Measuring alcohol consumption: psychosocial and biological methods; Totowa (NJ): Humana Press; 1992:41-72.
34. Bonn-Miller MO, Zvolensky MJ. An evaluation of the nature of marijuana use and its motives among young adult active users. Am J Addictions/Am Acad Psychiatrists Alcohol Addict 2009;18: 409-416.
35. Ihaka R, Gentleman R. R: a language for data analysis and graphics. J Computat Graphical Stat 1996;5:299-314.
36. Singer JD, Willett JB. Applied longitudinal data analysis: modeling change and event occurrence. Oxford/New York: Oxford University Press; 2003.
37. Miller GA, Chapman JP. Misunderstanding analysis of covariance. J Abnormal Psychol 2001;110:40-48.
38. Rooke SE, Norberg MM, Copeland J. Successful and unsuccessful cannabis quitters: comparing group characteristics and quitting strategies. Subst Abuse Treat, Prevent Policy 2011;6:30.
39. Degenhardt L, Hall W. The relationship between tobacco use, substance-use disorders and mental health: results from the National Survey of Mental Health and Well-being. Nicotine Tobacco Res 2001;3:225-234.
40. Buckner JD, Schmidt NB, Lang AR, Small JW, Schlauch RC, Lewinsohn PM. Specificity of social anxiety disorder as a risk factor for alcohol and cannabis dependence. J Psychiatric Res 2008; 42:230-239.
41. Marlatt GA. Harm reduction: come as you are. Addict Behav 1996; 21:779-788.
42. Babson KA, Bonn-Miller MO. Sleep disturbances: implications for cannabis use, cannabis use cessation, and cannabis use treatment. Curr Addict Rep 2014;1:109-114.
43. Budney AJ, Hughes JR, Moore BA, Vandrey R. Review of the validity and significance of cannabis withdrawal syndrome. Am J Psychiatry 2004;161:1967-1977.
44. Bonn-Miller MO, Zvolensky MJ, Marshall EC, Bernstein A. Incremental validity of anxiety sensitivity in relation to marijuana withdrawal symptoms. Addict Behav 2007;32:1843-1851.
45. Budney AJ, Moore BA, Vandrey RG, Hughes JR. The time course and significance of cannabis withdrawal. J Abnormal Psychol 2003; 112:393-402.
46. Vandrey R, Smith MT, McCann UD, Budney AJ, Curran EM. Sleep disturbance and the effects of extended-release zolpidem during cannabis withdrawal. Drug Alcohol Depend 2011;117:38-44.
47. Vandrey R, Stitzer ML, Mintzer MZ, Huestis MA, Murray JA, Lee D. The dose effects of short-term dronabinol (oral THC) maintenance in daily cannabis users. Drug Alcohol Depend 2013;128: 64-70.
48. Hjorthoj CR, Hjorthoj AR, Nordentoft M. Validity of timeline follow-back for self-reported use of cannabis and other illicit substances - systematic review and meta-analysis. Addict Behav 2012;37:225-233.
49. American Psychiatric Association (APA). Diagnostic and statistical manual of mental disorders: DSM-5, 5th ed. Washington, DC: APA; 2013.
50. Roffman RA, Stephens RS. Cannabis dependence: its nature, consequences, and treatment. Cambridge, UK/New York: Cambridge University Press; 2006.